Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 16th November 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product recall for Clindacutin Ointment
Dechra Regulatory B.V has issued a class III recall to the wholesale level.

The product has been manufactured according to the specifications of Dutch marketing authorisation.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall for all in-date batches of Clindacutin Ointment 10mg/g.

In a news release, the VMD writes: “We wish to make wholesalers and distributors aware that all in-date batches of Clindacutin Ointment 10 mg/g (Vm 50406/4011) are being recalled with immediate effect.

“Dechra Regulatory B.V has issued a class III recall to the wholesale level.

“The reason for the recall is that the product has been manufactured released according to specifications of the Dutch marketing authorisation which is not approved in this country.” 

The recall is for the following batches only BC (21H258) expiry date July 2023, and BB (21H244) expiry date July 2023.

Dechra Regulatory B.V is contacting wholesale dealers to examine inventory immediately and quarantine any products subject to recall. 

For more information please contact quality@dechra.com or externalnetwork.qa@dechra.com 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.